Puzo Michael J increased its position in shares of Danaher Co. (NYSE:DHR) by 32.6% in the 4th quarter, HoldingsChannel reports. The firm owned 55,456 shares of the conglomerate’s stock after purchasing an additional 13,627 shares during the period. Danaher accounts for approximately 2.1% of Puzo Michael J’s portfolio, making the stock its 22nd largest position. Puzo Michael J’s holdings in Danaher were worth $5,147,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of DHR. Beach Investment Management LLC. increased its position in shares of Danaher by 1,013.8% during the second quarter. Beach Investment Management LLC. now owns 53,460 shares of the conglomerate’s stock worth $4,511,000 after purchasing an additional 48,660 shares in the last quarter. Burney Co. increased its position in shares of Danaher by 20.8% during the second quarter. Burney Co. now owns 25,803 shares of the conglomerate’s stock worth $2,168,000 after purchasing an additional 4,438 shares in the last quarter. Alerus Financial NA increased its position in shares of Danaher by 0.4% during the second quarter. Alerus Financial NA now owns 32,887 shares of the conglomerate’s stock worth $2,775,000 after purchasing an additional 123 shares in the last quarter. Cannell Peter B & Co. Inc. increased its position in shares of Danaher by 1.1% during the second quarter. Cannell Peter B & Co. Inc. now owns 141,700 shares of the conglomerate’s stock worth $11,958,000 after purchasing an additional 1,499 shares in the last quarter. Finally, Pictet & Cie Europe SA increased its position in shares of Danaher by 2.4% during the second quarter. Pictet & Cie Europe SA now owns 133,766 shares of the conglomerate’s stock worth $11,289,000 after purchasing an additional 3,098 shares in the last quarter. Hedge funds and other institutional investors own 76.19% of the company’s stock.
In other news, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 12.20% of the company’s stock.
Several brokerages recently commented on DHR. Cowen reiterated a “buy” rating and set a $110.00 price target on shares of Danaher in a research report on Tuesday, January 30th. Credit Suisse Group restated an “outperform” rating and issued a $105.00 target price (up from $99.00) on shares of Danaher in a report on Wednesday, January 31st. Royal Bank of Canada restated a “hold” rating and issued a $98.00 target price on shares of Danaher in a report on Wednesday, January 31st. Morgan Stanley upped their target price on Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a report on Wednesday, January 31st. Finally, Stifel Nicolaus upped their target price on Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $100.13.
Danaher Co. (DHR) opened at $102.18 on Monday. Danaher Co. has a 12 month low of $78.97 and a 12 month high of $104.82. The company has a market capitalization of $71,178.59, a price-to-earnings ratio of 25.35, a PEG ratio of 2.20 and a beta of 1.04. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The business had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. During the same quarter in the prior year, the company posted $1.05 EPS. The company’s quarterly revenue was up 10.9% on a year-over-year basis. sell-side analysts expect that Danaher Co. will post 4.37 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.55%. The ex-dividend date was Thursday, December 28th. Danaher’s dividend payout ratio (DPR) is presently 15.86%.
ILLEGAL ACTIVITY WARNING: This story was originally reported by Stock Observer and is owned by of Stock Observer. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://www.thestockobserver.com/2018/02/05/puzo-michael-j-raises-position-in-danaher-co-dhr.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.